APOE and Alzheimer disease: Overexpression of ApoE4, the strongest genetic risk factor for the late onset of AD among the three major ApoE allelic variants (ε2, ε3, ε4) in humans [200,201], has been shown to alter lipid metabolism in astrocytes, increasing the utilization of endogenous FAs and LD formation [180].